Grifols, S.a. Share Price Today
(NASDAQ: GRFS)

Name: Grifols, S.a. Share Price Today (NASDAQ: GRFS) - Grifols, S.a. Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Grifols, S.a. share price is $7.08 & ₹605.09 as on 18 Apr 2025, 2.30 'hrs' IST

$7.08

▲

0.05

(0.71%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Grifols, S.a. share price in Dollar and Rupees. Guide to invest in Grifols, S.a. stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Grifols, S.a., along with analyst recommendations, forecasts, and comprehensive financials.

Grifols, S.a. share price movements

Today's Low: $6.97
Today's High: $7.15
$7.08
1.55%
Downside
Day's Volatility :2.52%
Upside
0.98%
52 Weeks Low: $5.79
52 Weeks High: $9.96
$7.08
18.22%
Downside
52 Weeks Volatility :41.87%
Upside
28.92%

Grifols, S.a. (GRFS) Returns

Period	Grifols, S.a.	Sector (Health Care)	Index (Russel 2000)
3 Months	-3.67%	-2.8%	0.0%
6 Months	-17.39%	-11.0%	0.0%
1 Year	12.74%	-1.9%	0.0%
3 Years	-37.23%	-1.5%	-12.9%

Grifols, S.a. (GRFS) Key Statistics

in dollars & INR

Previous Close	$7.03
Open	$7.03
Today's High	$7.15
Today's Low	$6.97
Market Capitalization	$5.7B
Today's Volume	$500.1K
52 Week High	$9.96
52 Week Low	$5.79
Revenue TTM	$7.2B
EBITDA	$1.6B
Earnings Per Share (EPS)	$0.26
PE Ratio	27.23
Profit Margin	2.18%
Quarterly Earnings Growth YOY	0.82%
Return On Equity TTM	2.64%

How to invest in Grifols, S.a. Stock (GRFS) from India?

It is very easy for Indian residents to invest directly in Grifols, S.a. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Grifols, S.a. stock in both Indian Rupees (INR) and US Dollars (USD). Search for Grifols, S.a. or GRFS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Grifols, S.a. or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Grifols, S.a. shares which would translate to 0.121 fractional shares of Grifols, S.a. as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Grifols, S.a., in just a few clicks!

Returns in Grifols, S.a. (GRFS) for Indian investors in Rupees

The Grifols, S.a. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Grifols, S.a. investment value today

Current value as on today

₹1,15,080

Returns

₹15,080

(+15.08%)

Returns from Grifols, S.a. Stock

₹12,739 (+12.74%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Grifols, S.a. (GRFS)

-29%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Grifols, S.a. Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Grifols, S.a.

Capital World Investors
3.11%
Brandes Investment Partners & Co
3.01%
Permian Investment Partners
2.38%
Black Creek Investment Management Inc
1.65%
Armistice Capital, LLC
1.48%
Millennium Management LLC
1.37%

Analyst Recommendation on Grifols, S.a.

Rating

Trend

Buy

63%Buy

22%Hold

13%Sell

Based on 22 Wall street analysts offering stock ratings for Grifols, S.a.(by analysts ranked 0 to 5 stars)

Analyst Forecast on Grifols, S.a. Stock (GRFS)

What analysts predicted

Upside of 53.04%

Target:

$10.84

Current:

$7.08

Insights on Grifols, S.a. Stock (Ticker Symbol: GRFS)

Price Movement
In the last 7 days, GRFS stock has moved up by 4.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 1.79B → 1.97B (in $), with an average increase of 9.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 14.84M → 68.96M (in $), with an average increase of 48.2% per quarter
GRFS vs LLY (3 yr)
In the last 3 years, Grifols, S.a. has experienced a drawdown of -35.7%, however Eli Lilly And Company resisted the overall trend and outperformed by 19.8%

GRFS Grifols, S.a. Financials in INR & Dollars

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY24	Y/Y Change
Revenue	$7.2B	↑ 9.41%
Net Income	$156.9M	↑ 164.55%
Net Profit Margin	2.18%	↑ 1.28%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q4 FY24	Q/Q Change
Revenue	$2.0B	↑ 10.2%
Net Income	$69.0M	↑ 33.42%
Net Profit Margin	3.49%	↑ 0.61%

FY19

FY20

FY21

FY22

FY23

FY24

	FY24	Y/Y Change
Profit	$2.8B	↑ 20.31%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q4 FY24	Q/Q Change
Profit	$766.5M	↑ 5.47%

FY19

FY20

FY21

FY22

	FY22	Y/Y Change
Operating Cash Flow	$-11.5M	↓ 101.82%
Investing Cash Flow	$-2.1B	↑ 6632.29%
Financing Cash Flow	$-183.6M	↓ 111.78%

Grifols, S.a. Technicals Summary

Sell

Neutral

Buy

Grifols, S.a. is currently in a neutral trading position according to technical analysis indicators.

Grifols, S.a. (GRFS) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Grifols, S.a.	-11.01%	-17.39%	12.74%	-37.23%	-66.29%
Eli Lilly And Company	-0.31%	-7.3%	15.65%	186.75%	432.33%
Johnson & Johnson	-5.59%	-3.29%	6.46%	-14.37%	3.82%
Merck & Co. Inc.	-19.29%	-26.65%	-37.99%	-9.78%	-6.14%
Novo Nordisk A/s	-26.29%	-50.5%	-52.67%	0.54%	81.19%
Abbvie Inc	-18.39%	-7.26%	3.95%	10.4%	105.96%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Grifols, S.a.	27.23	27.23	0.23	0.98	0.03	0.04	NA	8.65
Eli Lilly And Company	71.91	71.91	1.22	22.94	0.84	0.15	0.01	15.81
Johnson & Johnson	17.52	17.52	1.08	10.57	0.2	0.08	0.03	29.7
Merck & Co. Inc.	11.57	11.57	0.7	8.95	0.41	0.14	0.04	18.32
Novo Nordisk A/s	18.28	18.28	0.95	0.0	0.81	0.22	0.03	32.31
Abbvie Inc	72.38	71.83	0.37	12.23	0.62	0.08	0.04	1.88

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Grifols, S.a.	Buy	$5.7B	-66.29%	27.23	2.18%
Eli Lilly And Company	Buy	$754.3B	432.33%	71.91	23.51%
Johnson & Johnson	Buy	$379.5B	3.82%	17.52	24.42%
Merck & Co. Inc.	Buy	$196.3B	-6.14%	11.57	26.67%
Novo Nordisk A/s	Buy	$282.8B	81.19%	18.28	34.78%
Abbvie Inc	Buy	$306.0B	105.96%	72.38	7.59%

Grifols, S.a. Dividend announcements

Grifols, S.a. Dividends June, 2021
In the quarter ending June,2021. Grifols, S.a. has declared dividend of $0.46

About Grifols, S.a.

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma, and severe burns; alpha-1 proteinase inhibitor, a plasma protein, used to treat a genetic disease known as alpha-1; factor VIII/von Willebrand factor and factor IX, clotting factors for the treatment of hemophilia A and von Willebrand's disease, as well as hemophilia B; antithrombin III to treat hereditary antithrombin deficiency; Fostamatinib, a spleen tyrosine kinase inhibitor; combination of fibrinogen and enzyme thrombin that acts as a biological sealant to control surgical bleeding; and plasma exchange with albumin used to treat Alzheimer's disease. It also markets diagnostic testing equipment, reagents, and other equipment; offers biological products and manufacturing services; and manufactures and sells plasma to third parties. In addition, the company offers Yimmugo IDP, an immunology drug; Yimmugo PTI, a hematology drug; and Prolastin vials, a pulmonology drug. Further, it develops Xembify Pre-filled syringes, Gamunex Bags, and FlexBag; Xembify Biweekly dosing, Fibrinogen, and VISTASEAL; Prolastin-C AADT and Fostamatinib; Xembify " CLL, Albumina 20% and 5%, and Trimodulin; Alfa-1 AT 15%, GRF6019, GRF6021, Aßvac402, AKST4290, and AKST4290; GIGA 2339 and GIGA564; and recIG, Alfa-1 AT - in non-cystic fibrosis bronchiectasis, and OSIG that are in pre-clinical stage. It has collaboration agreements with Canadian Blood Services to supply grains of Immunoglobulin. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Organization	Grifols, S.a.
Employees	23833
CEO	Mr. Jose Ignacio Abia Buenache
Industry	Health Technology

Management People of Grifols, S.a.

Name	Title
Mr. Jose Ignacio Abia Buenache	CEO & Director
Ms. Nuria Pascual Lapeña	VP of Corporate Treasury, Risk Management Investor Relation & Sustainability Officer
Mr. David Ian Bell	Chief Corporate Affairs & Legal Officer

Important FAQs about investing in GRFS Stock from India :

What is Grifols, S.a. share price today?

Grifols, S.a. share price today stands at $7.08, Open: $7.03 ; Previous Close: $7.03 ; High: $7.15 ; Low: $6.97 ; 52 Week High: $9.96 ; 52 Week Low: $5.79.

The stock opens at $7.03, after a previous close of $7.03. The stock reached a daily high of $7.15 and a low of $6.97, with a 52-week high of $9.96 and a 52-week low of $5.79.

Can Indians buy Grifols, S.a. shares?

Yes, Indians can invest in the Grifols, S.a. (GRFS) from India.

With INDmoney, you can buy Grifols, S.a. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Grifols, S.a. at zero transaction cost.

How can I buy Grifols, S.a. shares from India?

It is very easy to buy Grifols, S.a. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Grifols, S.a. (GRFS) be purchased?

Yes, you can buy fractional shares of Grifols, S.a. with INDmoney app.

What are the documents required to start investing in Grifols, S.a. stocks?

To start investing in Grifols, S.a., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Grifols, S.a. Stock (GRFS)?

Today’s highest price of Grifols, S.a. (GRFS) is $7.15.

Today’s lowest price of Grifols, S.a. (GRFS) is $6.97.

What is today's market capitalisation of Grifols, S.a.?

Today's market capitalisation of Grifols, S.a. GRFS is 5.7B

What is the 52 Week High and Low Range of Grifols, S.a. Stock (GRFS)?

52 Week High
$9.96
52 Week Low
$5.79

What are the historical returns of Grifols, S.a. (GRFS)?

1 Month Returns
-11.01%
3 Months Returns
-17.39%
1 Year Returns
12.74%
5 Years Returns
-66.29%

Who is the Chief Executive Officer (CEO) of Grifols, S.a. ?

Mr. Jose Ignacio Abia Buenache is the current Chief Executive Officer (CEO) of Grifols, S.a..

Discover More

Ark Innovation Etf
$45.12
+0.09%
Restoration Hardware Holdings, Inc.
$161.13
+4.73%
Berry Plastics Group, Inc.
$67.60
+1.17%
Acadia Pharmaceuticals Inc.
$14.73
+1.1%
Newmark Group, Inc.
$10.39
+0.29%
Signet Jewelers Limited
$55.38
+0.86%
California Resources Corp
$35.68
+3.03%
Sl Green Realty Corp.
$52.39
+0.15%
Dfa Dimensional Internatl High Profitability Etf
$26.94
+1.22%

Explore all

	FY19	Y/Y Change
Revenue	$5.1B	↑ 13.64%
Net Income	$625.1M	↑ 4.78%
Net Profit Margin	12.26%	↓ 1.04%

	FY20	Y/Y Change
Revenue	$5.3B	↑ 4.73%
Net Income	$618.5M	↓ 1.06%
Net Profit Margin	11.58%	↓ 0.68%

	FY21	Y/Y Change
Revenue	$5.6B	↓ 7.62%
Net Income	$299.9M	↓ 57.1%
Net Profit Margin	5.38%	↓ 6.2%

	FY22	Y/Y Change
Revenue	$6.4B	↑ 22.92%
Net Income	$220.4M	↓ 21.5%
Net Profit Margin	3.43%	↓ 1.95%

	Q3 FY23	Q/Q Change
Revenue	$1.7B	↓ 3.97%
Net Income	$63.6M	↓ 0.82%
Net Profit Margin	3.73%	↑ 0.12%

	FY23	Y/Y Change
Revenue	$7.2B	↑ 8.71%
Net Income	$64.7M	↓ 71.52%
Net Profit Margin	0.9%	↓ 2.53%

	Q4 FY23	Q/Q Change
Revenue	$1.9B	↑ 10.77%
Net Income	$61.1M	↓ 5.96%
Net Profit Margin	3.16%	↓ 0.57%

	Q1 FY24	Q/Q Change
Revenue	$1.6B	↓ 8.13%
Net Income	$21.4M	↓ 61.75%
Net Profit Margin	1.32%	↓ 1.84%

	Q2 FY24	Q/Q Change
Revenue	$2.0B	↑ 11.82%
Net Income	$16.0M	↓ 30.71%
Net Profit Margin	0.82%	↓ 0.5%

	Q3 FY24	Q/Q Change
Revenue	$1.8B	↓ 1.37%
Net Income	$51.7M	↑ 248.3%
Net Profit Margin	2.88%	↑ 2.06%

	FY19	Y/Y Change
Operating Cash Flow	$568.9M	↓ 22.85%
Investing Cash Flow	$-548.8M	↓ 29.81%
Financing Cash Flow	$-332.4M	↓ 317.93%

	FY20	Y/Y Change
Operating Cash Flow	$1.1B	↑ 95.16%
Investing Cash Flow	$-858.1M	↑ 56.37%
Financing Cash Flow	$-354.4M	↑ 6.63%

	FY21	Y/Y Change
Operating Cash Flow	$674.9M	↓ 46.23%
Investing Cash Flow	$-33.2M	↓ 96.57%
Financing Cash Flow	$1.7B	↓ 515.61%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$166.1M	↓ 468.16%
Investing Cash Flow	$-131.2M	↑ 0.0%
Financing Cash Flow	$-84.7M	↓ 141.79%

Grifols, S.a. Share Price Today (NASDAQ: GRFS)

Grifols, S.a. share price movements

Grifols, S.a. (GRFS) Returns

Grifols, S.a. (GRFS) Key Statistics

How to invest in Grifols, S.a. Stock (GRFS) from India?

Returns in Grifols, S.a. (GRFS) for Indian investors in Rupees

Indian investors sentiment towards Grifols, S.a. (GRFS)

Global Institutional Holdings in Grifols, S.a.

Analyst Recommendation on Grifols, S.a.

Analyst Forecast on Grifols, S.a. Stock (GRFS)

Insights on Grifols, S.a. Stock (Ticker Symbol: GRFS)

Price Movement

Increasing Revenue

Increasing Net Profit

GRFS vs LLY (3 yr)

GRFS Grifols, S.a. Financials in INR & Dollars

Grifols, S.a. Technicals Summary

Grifols, S.a. (GRFS) Vs Peers

Grifols, S.a. Dividend announcements

Grifols, S.a. Dividends June, 2021

About Grifols, S.a.

Management People of Grifols, S.a.

Important FAQs about investing in GRFS Stock from India :

What is Grifols, S.a. share price today?

Can Indians buy Grifols, S.a. shares?

How can I buy Grifols, S.a. shares from India?

Can Fractional shares of Grifols, S.a. (GRFS) be purchased?

What are the documents required to start investing in Grifols, S.a. stocks?

What are today’s High and Low prices of Grifols, S.a. Stock (GRFS)?

What is today's market capitalisation of Grifols, S.a.?

What is the 52 Week High and Low Range of Grifols, S.a. Stock (GRFS)?

What are the historical returns of Grifols, S.a. (GRFS)?

Who is the Chief Executive Officer (CEO) of Grifols, S.a. ?

Discover More

Grifols, S.a. Share Price Today
(NASDAQ: GRFS)